A one-year-and-nine-month-old Filipino child battling a rare liver disease traveled to China Shanghai for a liver transplant surgery Chinese Ambassad ...

In a story of resilience and courage, a 59-year-old Emirati mother of five has triumphed over a second cancer diagnosis, this ...

Eisai has launched its new therapy for biliary tract cancer (BTC) Tasfygo in Japan, the first world market for the drug. Tasfygo (tasurgratinib succinate; formerly E7090), a small-molecule ...

Beyond improving accuracy, xAI allowed researchers to compare prognostic markers across different cancer types, unveiling ...

Study shows why there are differences in prognosis between different pancreatic tumours and identifies potential avenues for improved treatment approaches ...

Cancer recurs because of genetic mutations, its aggressive nature or limitations of treatment methods, say experts ...

Boston Scientific Co. (NYSE:BSX – Get Free Report) has been given an average recommendation of “Buy” by the twenty-three ...

Jan. 15, 2025 — New observational data and simulation models have confirmed a new type of planet unlike anything found in the Solar System. This provides another piece of the puzzle to ...

Pancreatic cancer patients may benefit from future precision treatments as a new study shows how some tumours may potentially be more susceptible to ...

Boston Scientific (NYSE:BSX – Free Report) had its price objective raised by Piper Sandler from $95.00 to $115.00 in a ...

Eli Lilly achieved the largest market capitalisation growth of 32.4% to $733bn in 2024, driven by strong demand for Mounjaro ...

The Phase 1b/2a study will assess the safety of CNP-103 in adults (aged 18-35) and pediatrics (aged 12-17) who have Stage III or newly diagnosed (within the last 6 months) T1D as well as C-peptide ...